A detailed history of New York State Common Retirement Fund transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 22,729 shares of BEAM stock, worth $659,368. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,729
Previous 31,529 27.91%
Holding current value
$659,368
Previous $739,000 24.63%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$22.57 - $33.14 $198,616 - $291,632
-8,800 Reduced 27.91%
22,729 $557,000
Q2 2024

Jul 31, 2024

BUY
$21.22 - $32.66 $11,310 - $17,407
533 Added 1.72%
31,529 $739,000
Q1 2024

May 07, 2024

BUY
$23.46 - $45.07 $55,600 - $106,815
2,370 Added 8.28%
30,996 $1.02 Million
Q4 2023

Feb 01, 2024

SELL
$17.69 - $30.76 $17,831 - $31,006
-1,008 Reduced 3.4%
28,626 $779,000
Q3 2023

Nov 07, 2023

BUY
$23.01 - $32.46 $6,051 - $8,536
263 Added 0.9%
29,634 $713,000
Q2 2023

Aug 07, 2023

SELL
$29.32 - $35.99 $460,939 - $565,798
-15,721 Reduced 34.86%
29,371 $938,000
Q1 2023

May 02, 2023

SELL
$30.15 - $48.79 $310,997 - $503,268
-10,315 Reduced 18.62%
45,092 $1.38 Million
Q4 2022

Jan 30, 2023

BUY
$36.73 - $51.6 $136,231 - $191,384
3,709 Added 7.17%
55,407 $2.17 Million
Q3 2022

Nov 08, 2022

BUY
$39.79 - $70.31 $61,674 - $108,980
1,550 Added 3.09%
51,698 $2.46 Million
Q2 2022

Aug 04, 2022

BUY
$29.86 - $62.36 $192,865 - $402,783
6,459 Added 14.78%
50,148 $1.94 Million
Q1 2022

May 05, 2022

BUY
$53.73 - $82.16 $196,114 - $299,884
3,650 Added 9.12%
43,689 $2.5 Million
Q4 2021

Feb 02, 2022

SELL
$68.02 - $99.06 $107,675 - $156,811
-1,583 Reduced 3.8%
40,039 $3.19 Million
Q3 2021

Nov 02, 2021

SELL
$84.37 - $133.6 $557,348 - $882,561
-6,606 Reduced 13.7%
41,622 $3.62 Million
Q2 2021

Aug 02, 2021

BUY
$64.12 - $128.71 $165,301 - $331,814
2,578 Added 5.65%
48,228 $6.21 Million
Q4 2020

Feb 08, 2021

BUY
$22.24 - $95.63 $272,440 - $1.17 Million
12,250 Added 36.68%
45,650 $3.73 Million
Q3 2020

Nov 05, 2020

BUY
$19.0 - $30.57 $298,300 - $479,949
15,700 Added 88.7%
33,400 $822,000
Q2 2020

Aug 07, 2020

BUY
$15.26 - $28.66 $169,386 - $318,126
11,100 Added 168.18%
17,700 $496,000
Q1 2020

May 06, 2020

BUY
$13.31 - $29.2 $87,846 - $192,720
6,600 New
6,600 $119,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.